CAIN CHRISTOPHER W. has filed 6 insider transactions across 4 companies since June 2024.
Most recent transaction: a grant/award of 37313 shares of Damora Therapeutics, Inc. ($DMRA) on March 23, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Damora Therapeutics, Inc. | $DMRA | CAIN CHRISTOPHER W. | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| July 1, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| June 4, 2025 | Cogent Biosciences, Inc. | $COGT | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 44700 | $0.00 | 44,700.0000 | 113,850,090 | 9999.99% | 0.04% |
| April 29, 2025 | Jade Biosciences, Inc. | $JBIO | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 81,484,950 | 9999.99% | 0.05% |
| June 5, 2024 | Cogent Biosciences, Inc. | $COGT | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 44700 | $0.00 | 44,700.0000 | 0 | 9999.99% | 0.00% |